COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 3038: Articles 30371-30380  | Next

Biophysical characterization of the SARS-CoV2 spike protein binding with the ACE2 receptor explains increased COVID-19 pathogenesis
Chowdhury, R., Maranas, C. D.
10.1101/2020.03.30.015891 — Posted: 2020-03-31
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach
Rahman, M. S., Hoque, M. N., Islam, M. R., Akter, S., Rubayet-Ul-Alam, A. S. M., Siddique, M. A., Saha, O., Rahaman, M. M., Sultana, M., Hossain, M. A.
10.1101/2020.03.30.015164 — Posted: 2020-03-31
Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein
Poh, C. M., Carissimo, G., Bei, W., Amrun, S. N., Lee, C. Y.-P., Chee, R. S.-L., Yeo, N. K.-W., Lee, W.-H., Leo, Y.-S., Chen, M. I.-C., Tan, S.-Y., Chai, L. Y. A., Kalimuddin, S., Thien, S.-Y., Young, B. E., Lye, D. C., Wang, C.-I., Renia, L., Ng, L. F.
10.1101/2020.03.30.015461 — Posted: 2020-03-31 Discussion: Onsite
Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design
Kames, J., Holcomb, D. D., Kimchi, O., DiCuccio, M., Hamasaki-Katagiri, N., Wang, T., Komar, A. A., Alexaki, A., Kimchi-Sarfaty, C.
10.1101/2020.03.30.016832 — Posted: 2020-03-31
Computational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics
Dick, K., Biggar, K. K., Green, J. R.
10.1101/2020.03.29.014381 — Posted: 2020-03-31
Fully human single-domain antibodies against SARS-CoV-2
Wu, Y., Li, C., Xia, S., Tian, X., Wang, Z., Kong, Y., Gu, C., Zhang, R., Tu, C., Xie, Y., Lu, L., Jiang, S., Ying, T.
10.1101/2020.03.30.015990 — Posted: 2020-03-31
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2
Chen, H.
10.1101/2020.03.30.015347 — Posted: 2020-03-31 Discussion: Onsite | Offsite
Lectin-like Intestinal Defensin Inhibits 2019-nCoV Spike binding to ACE2
Wang, C., Wang, S., Li, D., Zhao, X., Han, S., Wang, T., Zhao, G., Chen, Y., Chen, F., Zhao, J., Wang, L., Sun, W., Huang, Y., Su, Y., Wei, D., Zhao, J., Wang, J.
10.1101/2020.03.29.013490 — Posted: 2020-03-31 Discussion: Onsite | Offsite
Atlas of ACE2 gene expression in mammals reveals novel insights in transmission of SARS-Cov-2
Sun, K., Gu, L., Ma, L., Duan, Y.
10.1101/2020.03.30.015644 — Posted: 2020-03-31 Discussion: Onsite
Re-insights into origin and adaptation of SARS-CoV-2
Tagliamonte, M. S., Adid, N., Chillemi, G., Salemi, M., Mavian, C. N.
10.1101/2020.03.30.015685 — Posted: 2020-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).